Chelating agents for human diseases related to aluminium overload

被引：89
作者：
Crisponi, G. [1 ]
Nurchi, V. M. [1 ]
Bertolasi, V. [2 ,3 ]
Remelli, M. [2 ]
Faa, G. [4 ]
机构：
[1] Univ Cagliari, Dipartimento Sci Chim, I-09042 Cagliari, Italy
[2] Univ Ferrara, Dipartmento Chim, I-44121 Ferrara, Italy
[3] Univ Ferrara, Ctr Strutturist Diffrattometr, I-44121 Ferrara, Italy
[4] Univ Cagliari, Dipartimento Citomorfol, Div Anat Patolog, I-09042 Cagliari, Italy
来源：
COORDINATION CHEMISTRY REVIEWS | 2012年 / 256卷 / 1-2期
关键词：
Aluminium; Aluminium overload; Chelating agent; Complex formation constant; Aluminium related diseases; INTESTINAL-ABSORPTION; GASTROINTESTINAL ABSORPTION; DRINKING-WATER; BLADDER-CANCER; HUMAN-SERUM; METAL-IONS; AL-III; MACROPHAGIC MYOFASCIITIS; DIALYSIS ENCEPHALOPATHY; COORDINATION CHEMISTRY;
D O I：
10.1016/j.ccr.2011.06.013
中图分类号：
O61 [无机化学];
学科分类号：
070301 ; 081704 ;
摘要：
The aim of this review is to give a general view on the current status of the role of aluminium in human health and disease. The main aspects of aluminium metabolism in humans are covered, summarizing the state of knowledge on the absorption, distribution, retention and excretion of aluminium, giving particular emphasis to the main metabolic pathways of this metal ion in different organs. Then the pathological consequences of aluminium overload in man, its role in neurodegenerative diseases and the emerging implication of this metal ions in different pathologies are treated. Finally, the function of different chelators utilized in clinical practice in the therapy of aluminium depending diseases is discussed and the latest studies on aluminium chelators are presented. Some emphasis is given to the parallelism between iron and aluminium chelators, and in particular interesting correlations between structural parameters of these two trivalent metal ions are presented. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码：89 / 104
页数：16
相关论文
共 274 条
  • [1] ABREO K, 1991, J AM SOC NEPHROL, V1, P1299
  • [2] Aluminum citrate is transported from brain into blood via the monocarboxylic acid transporter located at the blood-brain barrier
    Ackley, DC
    Yokel, RA
    [J]. TOXICOLOGY, 1997, 120 (02) : 89 - 97
  • [3] ACKRILL P, 1980, LANCET, V2, P692
  • [4] Safety of aluminium from dietary intake
    Aguilar, F.
    Autrup, H.
    Barlow, S.
    Castle, L.
    Crebelli, R.
    Dekant, W.
    Engel, K. -H.
    Gontard, N.
    Gott, D.
    Grilli, S.
    Guertler, R.
    Larsen, J. -C.
    Leclercq, C.
    Leblanc, J. -C.
    Malcata, F. -X.
    Mennes, W.
    Milana, M. -R.
    Pratt, I.
    Rietjens, I.
    Tobback, P.
    Toldra, F.
    [J]. EFSA JOURNAL, 2008, 6 (07)
  • [5] Metallomic Profiling and Linkage Map Analysis of Early Parkinson's Disease: A New Insight to Aluminum Marker for the Possible Diagnosis
    Ahmed, Shiek S. S. J.
    Santosh, Winkins
    [J]. PLOS ONE, 2010, 5 (06):
  • [6] A POTENTIAL IRON PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IRON-DEFICIENCY ANEMIA - THE CRYSTAL AND MOLECULAR-STRUCTURE OF MER-TRIS-(3-HYDROXY-2-METHYL-4H-PYRAN-4-ONATO)IRON(III)
    AHMET, MT
    FRAMPTON, CS
    SILVER, J
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1988, (05): : 1159 - 1163
  • [7] INTERACTIVE EFFECTS OF FLUORIDE AND ALUMINUM UPTAKE AND ACCUMULATION IN BONES OF RABBITS ADMINISTERED BOTH AGENTS IN THEIR DRINKING-WATER
    AHN, HW
    FULTON, B
    MOXON, D
    JEFFERY, EH
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1995, 44 (03): : 337 - 350
  • [8] Albrecht-Gary AM, 1998, MET IONS BIOL SYST, V35, P239
  • [9] Alexandrov PN, 2005, J ALZHEIMERS DIS, V8, P117
  • [10] Alfrey A.C., 1991, ALUMINUM CHEM BIOL M, P73
12345678910